The International journal of pharmacy practice · 2026
Anticoagulant stewardship: an opportunity for community pharmacy.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wilcock Michael, Bastian Liam
Аннотация
OBJECTIVES: This study explored how community pharmacies in the English National Health Service responded to a referral from one hospital in the south west of England for a discharge medicines service for patients on oral anticoagulants.
METHODS: Analysis of PharmOutcomes™ for a 12-month period commencing 1 April 2023. The download was interrogated for relevant entries for patients discharged on apixaban, dabigatran, edoxaban, rivaroxaban, or warfarin.
KEY FINDINGS: Approximately one-third of community pharmacies recorded entries on PharmOutcomes™ that point to their involvement in monitoring of appropriate prescribing and active counselling of patients about their anticoagulants at transition of care.
CONCLUSIONS: There is increased scope for community pharmacists to be involved more formally in anticoagulant stewardship activities.
METHODS: Analysis of PharmOutcomes™ for a 12-month period commencing 1 April 2023. The download was interrogated for relevant entries for patients discharged on apixaban, dabigatran, edoxaban, rivaroxaban, or warfarin.
KEY FINDINGS: Approximately one-third of community pharmacies recorded entries on PharmOutcomes™ that point to their involvement in monitoring of appropriate prescribing and active counselling of patients about their anticoagulants at transition of care.
CONCLUSIONS: There is increased scope for community pharmacists to be involved more formally in anticoagulant stewardship activities.